Catalyst Advisors LP, the partner-led executive and board recruitment firm specializing in biotech, biopharma and life sciences, ...

Physicians say a pioneering 3D printer can revolutionize care for people battling gynecological cancer. Using each patient’s ...

Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...

Corsera, which emerged in September 2025, aims to extend healthspan by reducing the risk of atherosclerotic cardiovascular ...

Texas A&M AgriLife faculty, staff and graduate students earn Vice Chancellor’s Awards in Excellence honors at Texas A&M ...

The partnership between the American University in Cairo (AUC) and Minapharm Pharmaceuticals, which gets underway early this year, will contribute to establishing what the university describes as the ...

In a landscape where precision is paramount, the base editing market is emerging as a cornerstone of modern biotechnology, ...

As the Trump administration cuts funding to wide swaths of research, foreign countries are ramping up their efforts to ...

The University of North Texas at Dallas' new STEM center will train local students for high-demand, high-wage jobs in the ...

If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...

AbbVie is opening submissions for an award that will provide one Canadian biotech with free access to lab space and executive insights from the Big Pharma. The most recent iteration of the program, ...

Swedish biotech Sprint Bioscience is selling off an early-stage TREX1 cancer program to Gilead Sciences for $14 million upfront, plus the chance to net up to $400 million in biobucks. Last year, ...